Author(s): Shinto L, Calabrese C, Morris C, Yadav V, Griffith D, et al.
Background:Complementary and alternative medicine (CAM) use is high in people with multiple sclerosis (MS), yet there are limited reports on safety and effectiveness of CAM in MS. Naturopathic medicine encompasses a broad range of CAM modalities and may improve quality of life in patients with MS.
Objective:To assess quality of life in MS subjects who received interventions designed to "model" the "whole practice" of naturopathy.
Design:A pilot, randomized, controlled study with a 6-month intervention period.
Participants:Participants who met criteria for clinically definite MS.
Interventions:The 3 intervention arms were usual care, naturopathic medicine plus usual care, and MS education plus usual care.
Outcome measures:The primary outcome measure was quality of life (36-item short form health survey [SF-36]). Secondary outcome measures included fatigue (Modified Fatigue Impact Scale); depression (Beck Depression Inventory); cognition battery (Stroop test and Paced Auditory Serial Addition Test 3), and neurologic impairment (Expanded Disability Status Scale [EDSS] and Multiple Sclerosis Functional Composite). Adverse event reporting and laboratory measures were used to assess safety.
Results:Forty-five (45) participants (15 per group) were randomized and all completed the 6-month intervention. There were no significant differences between groups on any outcome measure. There was a trend in favoring the naturopathic group in the General Health subscale of the SF-36 (p = 0.11), Timed Walk (p = 0.11), and neurologic impairment (EDSS) (p = 0.07). There was a trend favoring the Education group in the Stroop attention test (p = 0.07). There was no difference between groups in adverse events or laboratory changes.
Conclusions:Naturopathic medicine combined with usual care for MS showed a trend in improvement in the General Health subscale of the SF-36, Timed Walk, and neurologic impairment. Evaluation of naturopathic medicine, as a multimodality regimen, warrants further investigation.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/18532899
Author(s): Hassan-Smith G, Douglas MR
Author(s): Río J, Comabella M, Montalban X
Author(s): Yadav V, Shinto L, Bourdette D
Author(s): Leong EM, Semple SJ, Angley M, Siebert W, Petkov J, et al.
Author(s): Marrie RA, Hadjimichael O, Vollmer T
Author(s): Schwarz S, Knorr C, Geiger H, Flachenecker P
Author(s): Rezapour-Firouzi S, Arefhosseini SR, Mehdi F, Mehrangiz EM, Baradaran B, et al.
Author(s): vonGeldern G, Mowry EM
Author(s): Fetterman JW Jr, Zdanowicz MM
Author(s): Lands WE
Author(s): Calder PC
Author(s): Burdge GC, Calder PC
Author(s): Calder PC
Author(s): Yates CM, Calder PC, Ed Rainger G
Author(s): Gorjão R, Azevedo-Martins AK, Rodrigues HG, Abdulkader F, Arcisio-Miranda M, et al.
Author(s): Iwami D, Nonomura K, Shirasugi N, Niimi M
Author(s): Bates D, Cartlidge NE, French JM, Jackson MJ, Nightingale S, et al.
Author(s): Gallai V, Sarchielli P, Trequattrini A, Franceschini M, Floridi A, et al.
Author(s): Neu I, Mallinger J, Wildfeuer A, Mehlber L
Author(s): Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, et al.
Author(s): Sierra S, Lara-Villoslada F, Comalada M, Olivares M, Xaus J
Author(s): Verlengia R, Gorjão R, Kanunfre CC, Bordin S, Martins De Lima T, et al.